HER2 IHC3+ Advanced Colorectal Cancer
1 clinical trials · Condition
◉ Watch HER2 IHC3+ Advanced Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs (NCT07483684) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2026-03-01 |
Track HER2 IHC3+ Advanced Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.